Decreased Expression of Sulfatase 2 in the Brains of Alzheimer’s Disease Patients: Implications for Regulation of Neuronal Cell Signaling

Abstract

Background The human sulfatase 1 (SULF1) and sulfatase 2 (SULF2) genes modulate cell signaling and homeostasis in many tissues. Gene expression analyses have implicated SULF2 in disease pathogenesis, including Alzheimer’s disease (AD), but changes in brain SULF2 expression have not been directly established. Objective To investigate the expression of SULF1 and SULF2 in brain tissues from AD cases and cognitively normal controls. Methods Autopsy tissue from AD cases (n = 20) and age-and gender-matched cognitively normal controls (n = 20) were identified from the Mayo Clinic Alzheimer’s Disease Patient Registry neuropathology database. Tissue slides were stained for SULF1 and SULF2 protein expression in the hippocampus and frontal lobe and an expression score computed from the proportion of cells stained and the intensity of staining (range 0 [no expression] to 9 [marked expression]). Results SULF2 expression was reduced in AD cases. Compared to cognitively normal controls, SULF2 expression in AD cases was significantly decreased in the hippocampal Cornu Ammonis (CA) (mean score of 6.5 in cases versus 8.3 in controls; p = 0.003), in the gray matter of the parahippocampal gyrus (5.6 in cases versus 7.6 in controls; p = 0.003), and in the frontal lobe gray matter (5.4 in cases versus 7.4 in controls; p = 0.002). There was no difference in SULF1 expression in the hippocampus or frontal lobe of AD cases and controls. As expected there were no differences in SULF1 or SULF2 expression in white matter in AD cases compared to cognitively normal controls. Conclusion Decresed SULF2 in specific regions of the brain occurs in AD.

Parallel molecular alteration between Alzheimer’s disease and major depressive disorder in the human brain dorsolateral prefrontal cortex: an insight from gene expression and methylation profile analyses

“…Our results support the importance of DNA methylation alteration in AD and MDD pathology and highlight the value of scrutinizing the exact role of some hyper-or hypomethylated genes in future studies. Our presented DNA methylation changes in HSPG2, DAB2IP, ARHGAP22, TXNRD1, MYO10, SDK1 and KRT82 in DLPFC brain tissue of cases with AD and MDD have confirmed some former research (Table 2) (Soerensen et al, 2008;Kaut et al, 2015;Roberts et al, 2017;Lutz et al, 2020). Also, DNA methylation changes of MYO10 in three independent brain cohorts were reported before (De Jager et al, 2014).…”

Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk

“…Amongst the heat shock proteins, we found Hspa4 to be upregulated which ensured that it maintained the disaggregating property of any misfolded proteins, thereby, preventing further damage and inducing tissue integrity 89 . Additionally, it also helped in sulfatase gene (Sumf2) maintenance which is associated with modulation of tissue homeostasis 90 . Interestingly, long term infection also induced expressions of Ezr 91 and Cldn5 92 which are associated with maintenance of actin cytoskeletal structure, synapse and tight junctions, respectively.…”

Age patterns of intra‐pair DNA methylation discordance in twins: Sex difference in epigenomic instability and implication on survival

“…Genetic variation of FAM19A1 has been found to associate with human longevity in a large scale genome‐wide association study (Zeng et al, 2018 ). Decreased expression of SULF2 was found in Alzheimer's disease patients indicating its implication in regulating neuronal signaling (Roberts et al, 2017 ).…”